Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Cardiology

Does dual antiplatelet therapy reduce the risk of death for MINOCA patients?

Pooled data suggest dual antiplatelet therapy (DAPT) may lower the risk of all-cause death in MINOCA patients, but it does not appear to reduce heart attacks or major adverse…

Cardiology

Is autologous pericardial annuloplasty effective at reducing Tricuspid Regurgitation recurrence?

Autologous pericardial annuloplasty is associated with a significantly lower rate of moderate tricuspid regurgitation recurrence at 48 and 96 months compared to prosthetic ring…

Cardiology

Does the TWEAK-Fn14 axis contribute to myocardial fibrosis?

The TWEAK-Fn14 axis is implicated in several pathological processes in the heart, including inflammation, hypertrophy, and fibrosis.

Cardiology

Can Traditional Chinese Medicine help treat myocardial fibrosis?

Traditional Chinese Medicine (TCM) shows promise in research for treating myocardial fibrosis by targeting specific cellular pathways and improving mitochondrial health.

Cardiology

Is vitamin D lower in Graves' disease compared to healthy people?

Yes. Studies generally find lower vitamin D levels in people with Graves' disease than in healthy controls, though the gap is modest and one study's deficiency-risk estimate was…

Cardiology

Does paclitaxel-coated balloon angioplasty improve the 6-month patency of an arteriovenous fistula?

Yes, a 2026 randomized trial found that a scoring paclitaxel-coated balloon improved 6-month target lesion patency of failing arteriovenous fistulas compared with a plain balloon…

Cardiology

Does paclitaxel-coated balloon angioplasty improve the patency of a malfunctioning arteriovenous fistula?

Yes. A 2026 multicenter randomized trial found that a scoring paclitaxel-coated balloon improved 6-month target lesion primary patency (78.9% vs 57.3%) compared with plain…

Cardiology

What types of self-management programs are available for patients with an arteriovenous fistula?

Self-management programs for arteriovenous fistulas (AVFs) can include physical therapy, respiratory exercises, and programs based on various behavioral and nursing theories.

Cardiology

Do beta-blockers improve heart function in patients with cardiotoxicity?

Beta-blockers may help preserve heart pumping function in some cancer patients receiving cardiotoxic chemotherapy, but the evidence is mixed and depends on the cause and setting…

Cardiology

What are the risk factors for trastuzumab-induced cardiotoxicity?

The biggest risk factor for trastuzumab-induced cardiotoxicity is prior anthracycline chemotherapy; other risks include older age, existing heart disease, high blood pressure…

Cardiology

Is ticagrelor monotherapy safe for patients who have just had a STEMI?

Small pilot trials in STEMI patients suggest ticagrelor monotherapy right after primary PCI may reduce bleeding without a clear rise in ischemic events, but the evidence is too…

Cardiology

Does a pressure optimization protocol improve reperfusion for STEMI patients?

Yes. A large randomized trial found that a pressure optimization protocol during primary PCI for STEMI improved reperfusion success compared with conventional rapid…

Cardiology

Does primary aldosteronism cause lower potassium levels in the blood?

Yes. Primary aldosteronism is consistently linked to lower blood potassium levels, and the drop is larger in more severe or unilateral cases [1][2][6].

Cardiology

What is the rate of in-stent restenosis after vertebral artery ostial stenting?

In-stent restenosis after vertebral artery ostial stenting occurs in about 13.5% to 37.2% of cases, depending on the study and follow-up duration.

Cardiology

What is the risk of kidney injury after surgery for type A aortic dissection?

About half of patients develop acute kidney injury after type A aortic dissection surgery, with higher risk in older patients, those with renal malperfusion, and longer bypass…

Cardiology

Can immune interactions drive remodeling in patients with aortic aneurysms and dissections?

Immune interactions, particularly involving T cells and the communication between vascular smooth muscle cells and immune cells, play a significant role in driving tissue…

Cardiology

Do people with SDHD mutations often develop multiple pheochromocytoma tumors?

People with SDHD mutations are frequently associated with multifocal tumors, which can include multiple pheochromocytoma or paraganglioma sites.

Cardiology

Do GLP-1 receptor agonists reduce limb complications for people diagnosed with Peripheral Artery Disease?

GLP-1 receptor agonists reduce major adverse limb events (MALE) and cardiovascular risks in people with type 2 diabetes and peripheral artery disease, based on meta-analyses.

Cardiology

Do GLP-1 receptor agonists reduce major limb events for patients with Peripheral Artery Disease?

Yes, GLP-1 receptor agonists reduce major limb events in patients with type 2 diabetes and peripheral artery disease, with a 27% lower risk shown in a 2026 meta-analysis.

Cardiology

Can tirzepatide provide cardiovascular benefits for people living with Peripheral Artery Disease?

Yes, tirzepatide may reduce major adverse limb events and cardiovascular risks in people with PAD, but direct trial data are still limited.

Cardiology

What are the cardiovascular benefits of using incretin analogues in Peripheral Artery Disease?

Incretin analogues (GLP-1 RAs) reduce cardiovascular risk in PAD by improving walking distance, lowering inflammation, and decreasing heart attack and stroke events.

Cardiology

Do SGLT2 inhibitors lower mortality rates in patients with transthyretin cardiomyopathy?

SGLT2 inhibitors may lower all-cause mortality in transthyretin cardiomyopathy, but evidence is mixed; one study shows benefit, another shows no mortality reduction when added to…

Cardiology

Does furosemide plus hypertonic saline lower biomarker levels in acute decompensated heart failure?

Yes, furosemide plus hypertonic saline is linked to lower increases in biomarkers like NT-proBNP, IL-6, and sST2 after a saline load in ADHF patients, though baseline reductions…

Cardiology

Can natriuresis-guided protocols help with weight loss in acute decompensated heart failure?

Yes, natriuresis-guided protocols increase weight loss in acute decompensated heart failure, with a meta-analysis showing about 0.45 kg more weight loss at 48 hours compared to…

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.